RIL
ACUR

Rothschild Investment LLC’s Acura Pharmaceuticals ACUR Stock Holding History

Rothschild Investment LLC’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-20,000
Closed -$45K – 524
2014
Q4 		$45K Buy
+20,000
New +$55.3K 0.01% 496

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Rothschild Investment LLC's ACUR Position: Q1 2015 in Review

Rothschild Investment LLC sold out of Acura Pharmaceuticals (ACUR) in Q1 2015, closing a stake of 20,000 shares — an estimated $45K sold.

Rothschild Investment LLC first reported a position in ACUR in Q4 2014 and held it in 1 quarter. The position peaked at $45K in Q4 2014. 27 funds tracked by Wall St. Rank hold ACUR as of Q1 2015.

  • Rothschild Investment LLC reported no remaining Acura Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Rothschild Investment LLC sold 20,000 Acura Pharmaceuticals shares in Q1 2015, an estimated $45K.
  • Rothschild Investment LLC first reported a position in Acura Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • Rothschild Investment LLC's Acura Pharmaceuticals position peaked at $45K in Q4 2014.
  • 27 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2015.

Based on Rothschild Investment LLC's 13F filing for Q1 2015, filed 28 Apr 2015.